Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of Intervention

The clinical standard of care for urothelial carcinoma (UC) relies on invasive procedures with suboptimal performance. To enhance UC treatment, we developed a urinary comprehensive genomic profiling (uCGP) test, UroAmplitude, that measures mutations from tumor DNA present in urine. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Bicocca, Vincent T., Phillips, Kevin G., Fischer, Daniel S., Caruso, Vincent M., Goudarzi, Mahdi, Garcia-Ransom, Monica, Lentz, Peter S., MacBride, Andrew R., Jensen, Brad W., Mazzarella, Brian C., Koppie, Theresa, Korkola, James E., Gray, Joe W., Levin, Trevor G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571552/
https://www.ncbi.nlm.nih.gov/pubmed/36233691
http://dx.doi.org/10.3390/jcm11195827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571552/
https://www.ncbi.nlm.nih.gov/pubmed/36233691
http://dx.doi.org/10.3390/jcm11195827

Ejemplares similares